CUSIP 75340L104CLASS A COMRPIDQ4 2025
22 filings · latest Feb 13, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Bain Capital Life Sciences Investors, LLC | 8.43M | $24.46M |
| 2 | Abg-Wtt Global Life Science Capital Partners Gp Ltd | 1.85M | $5.36M |
| 3 | Vanguard Group Inc | 978.8K | $2.84M |
| 4 | Advent International, L.P. | 577.8K | $1.68M |
| 5 | Parkman Healthcare Partners LLC | 354.5K | $1.03M |
| 6 | Schonfeld Strategic Advisors LLC | 352.4K | $1.02M |
| 7 | Geode Capital Management, LLC | 217.6K | $631.1K |
| 8 | Susquehanna International Group, LLP | 172.2K | $499.5K |
| 4 | Jan 22, 2024 | Endeavour Medtech Growth II LP | 13G/A | 6.0% | 2.26M | SEC |
| 5 | Feb 14, 2023 | T. Rowe Price Investment Management, Inc. | 13G | 6.0% | 2.19M | SEC |
| 6 | Feb 14, 2023 | Longitude Capital Partners II, LLC | 13G/A | 10.9% | 4.04M | SEC |
| 7 | Feb 14, 2023 | D1 Capital Partners L.P. | 13G/A | — | — | SEC |
| 8 | Feb 14, 2023 | Price T Rowe Associates Inc /Md/ | 13G/A | 2.2% | 800.5K | SEC |
| 9 | Feb 8, 2023 | Colony Harvest Ltd | 13G/A | 4.5% | 1.62M | SEC |
| 10 | Nov 7, 2022 | Jpmorgan Chase & Co | 13G/A | 3.8% | 1.40M | SEC |
See the full Schedule 13D/13G history for Rapid Micro Biosystems Inc.
Unlock full history| 9 | Evernest Financial Advisors, LLC | 125.0K | $468.8K |
| 10 | Blackrock, Inc. | 156.7K | $454.3K |